top of page
Image-empty-state_edited.jpg

PhorMed

Favorite-Icon-p-1600.png
Favorite-Icon-p-1600_filled.png
Login to favorite a company
Utilizing gene therapy to target cancer and mutated cells
Most Recent Valuation:

$51,600,000.00

Legal Name:
Founded:
State of HQ:

Phormed Inc

5/15/2019

CA

Company Description

Employees:

[]

Funding Summary

Number of funding rounds
#
Total amount raised
$2,690,971
Round name
End date
Raised
Status
Type
Investment minimum
Valuation
Valuation Cap
Price per share
PhorMed Common Stock 2
08/18/2022
$240,443.00
closed
Common Stock
$500
$51,600,000
1
PhorMed Stock 1
03/26/2022
$2,450,528.00
closed
Common Stock
$250
$39,000,000
1
Screen Shot 2020-07-15 at 12.01.28 PM.pn

See round history

Round history

Round name
Perk description
Perk level (dollars)
Perk level (days)
Loading...

Early Bird Perk history

Screen Shot 2020-07-15 at 12.01.28 PM.pn

View early bird perks, deal notes, company financials, and more

Company notes

Type
Round name
Date Added
Date Updated
Notes
Loading...

Financials (up to prior 4 years)

Revenue
COGS
Gross margin | (%)
Taxes
SG&A, other
Net income
Cash/Equivalents
Accounts Receiv
Other Assets
Assets
Short term debt
Long term debt
Equity/other liabilities

Gross margin, Other Assets, and Equity/other liabilities are derived from the financial statements of the company reported to the SEC. Assets = Liabilities + Equity, and no equity accounts nor accounts payable are reported to the SEC, hence the possibility for that amount to be either equity or a liability.

bottom of page